Studies have indicated that Semaglutide can reduce the risk of major cardiovascular events such as heart attack, stroke, and cardiovascular-related death
People who prioritize seven to nine hours of quality sleep and manage stress effectively tend to see faster and more consistent results
Ma J, Shi M, Zhang X, Liu X, Chen J, Zhang R, Wang X, Zhang H (2018) GLP1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NFkappaB signaling pathways in streptozotocininduced diabetic rats
However, high list prices for medications can have a disproportionate impact on marginalized and lower-wage populations, especially those without insurance coverage for these medications
Answer: Semaglutide is a GLP-1 receptor agonist, a prescription medication originally developed for type 2 diabetes and now FDA-approved for chronic weight management, given as a once-weekly injection that reduces appetite and slows digestion